Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system (CNS) disorders, today announces that the first patient in the TREE study ...

Research Demonstrates GDNF's Ability to Prevent and Reverse Obesity by Enhancing Fat Metabolism and Energy ExpenditureHoth is developing this therapeutic in Partnership with the Department of Veterans ...

Hoth Therapeutics (HOTH) announced preclinical findings that highlight the potential of Glial Cell Line-Derived Neurotrophic Factor, or GDNF, ...

To improve access to innovative medicines, the ministry implemented accelerated registration pathways and schemes like the Patient Access Scheme (PASc) and the Patient Assisted Programme (Special ...

This initiates a whole metabolic pathway with different steps that eventually ... The study assesses whether peroxisome proliferator-activated receptor (PPAR) β/δ can regulate InsRβ levels ...

This initiates a whole metabolic pathway with different steps that eventually ... The study assesses whether peroxisome proliferator-activated receptor (PPAR) β/δ can regulate InsRβ levels ...

This initiates a whole metabolic pathway with different steps that eventually ... The study assesses whether peroxisome proliferator-activated receptor (PPAR) β/δ can regulate InsRβ levels ...